Proteros Biostructures GmbH has announced that it has renewed its agreement with Rigel Pharmaceuticals, Inc. to provide structural biology services for a Rigel drug discovery program. Under this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results